Published in J Exp Med on February 03, 2003
Mimotopes for alloreactive and conventional T cells in a peptide-MHC display library. PLoS Biol (2004) 1.40
The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden. Infect Immun (2012) 1.01
Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts. Transplantation (2011) 0.91
Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach. J Virol (2006) 0.78
Distributions of single nucleotide polymorphisms in differential chromosome segments of congenic resistant strains that define minor histocompatibility antigens. Immunogenetics (2007) 0.75
Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A (1993) 9.17
The central role of CD4(+) T cells in the antitumor immune response. J Exp Med (1998) 6.02
Sequence analysis of peptides bound to MHC class II molecules. Nature (1991) 5.99
LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol (1994) 3.47
On the complexity of self. Nature (1991) 3.43
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science (1995) 2.55
Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol (2001) 2.51
Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol (1994) 2.08
Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. Science (1999) 2.01
Identification of a mouse male-specific transplantation antigen, H-Y. Nature (1995) 1.82
Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods (1995) 1.76
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med (2001) 1.53
The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu Rev Immunol (1997) 1.46
Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature (1990) 1.45
The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood (2002) 1.41
Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science (1994) 1.32
Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity (2000) 1.29
Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J Immunol (1998) 1.26
Fig1, an interleukin 4-induced mouse B cell gene isolated by cDNA representational difference analysis. Proc Natl Acad Sci U S A (1997) 1.18
Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins. Proc Natl Acad Sci U S A (1995) 1.17
Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning. J Exp Med (1995) 1.14
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol (2001) 1.14
Perspective on antigen processing and presentation. Immunol Rev (2002) 1.09
Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. Immunity (1997) 1.08
A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism. J Immunol (1994) 1.04
What are minor histocompatibility loci? A new look at an old question. Immunol Today (1992) 0.99
Characterization of the human homolog of the IL-4 induced gene-1 (Fig1). Biochim Biophys Acta (2002) 0.97
A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes. J Virol (1992) 0.95
Bacterial surface proteins recognized by CD4+ T cells during murine infection with Listeria monocytogenes. J Immunol (1998) 0.90
Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis. J Exp Med (2002) 0.88
Complexity at the mouse minor histocompatibility locus H-4. Immunogenetics (1990) 0.84
Distinguishing self from nonself: immunogenicity of the murine H47 locus is determined by a single amino acid substitution in an unusual peptide. J Immunol (2001) 0.84
Needles in haystacks: identifying specific peptide antigens for T cells. Curr Opin Immunol (1996) 0.78
ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature (2002) 3.72
In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol (2006) 2.62
Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat Immunol (2008) 2.45
Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science (2012) 2.30
The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol (2005) 2.24
Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity (2006) 2.18
A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels. Proc Natl Acad Sci U S A (2003) 2.14
Constitutive display of cryptic translation products by MHC class I molecules. Science (2003) 1.67
Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect Immun (2005) 1.66
Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J Immunol (2010) 1.46
Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes. J Control Release (2009) 1.44
ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity (2006) 1.43
Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol (2004) 1.29
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol Med (2013) 1.28
A distinct translation initiation mechanism generates cryptic peptides for immune surveillance. PLoS One (2008) 1.26
The final touches make perfect the peptide-MHC class I repertoire. Immunity (2007) 1.23
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade. Proc Natl Acad Sci U S A (2008) 1.22
In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc Natl Acad Sci U S A (2005) 1.22
The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. Mol Cell (2003) 1.21
Coping with loss of perfection in the MHC class I peptide repertoire. Curr Opin Immunol (2008) 1.21
Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol (2012) 1.14
Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model. Bioconjug Chem (2004) 1.08
A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice. J Immunol (2002) 1.04
The synthesis of truncated polypeptides for immune surveillance and viral evasion. PLoS One (2010) 1.04
Non-conventional sources of peptides presented by MHC class I. Cell Mol Life Sci (2011) 1.03
The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden. Infect Immun (2012) 1.01
Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27. Arthritis Rheumatol (2014) 1.00
Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite. PLoS Pathog (2013) 0.98
Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes. Mol Ther (2008) 0.93
ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. J Immunol (2013) 0.90
Endoplasmic reticulum aminopeptidase associated with antigen processing regulates quality of processed peptides presented by MHC class I molecules. J Immunol (2008) 0.90
Topological journey of parasite-derived antigens for presentation by MHC class I molecules. Trends Immunol (2010) 0.89
How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination. J Immunol (2002) 0.89
Immune surveillance for ERAAP dysfunction. Mol Immunol (2013) 0.85
Cross-presentation of peptides from intracellular pathogens by MHC class I molecules. Ann N Y Acad Sci (2010) 0.83
Mousepox detected in a research facility: case report and failure of mouse antibody production testing to identify Ectromelia virus in contaminated mouse serum. Comp Med (2009) 0.81
Biochemical analysis of naturally processed antigenic peptides presented by MHC class I molecules. Methods Mol Biol (2013) 0.77
Construction and destruction of MHC class I in the peptide-loading complex. Nat Immunol (2007) 0.75
Immune surveillance obstructed by viral mRNA. Proc Natl Acad Sci U S A (2008) 0.75